CareDx PE Ratio 2013-2023 | CDNA
Current and historical p/e ratio for CareDx (CDNA) from 2013 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CareDx PE ratio as of March 27, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
CareDx PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-03-28 | 10.59 | 0.00 | |
2023-12-31 | 12.00 | $-3.54 | 0.00 |
2023-09-30 | 7.00 | $-1.67 | 0.00 |
2023-06-30 | 8.50 | $-1.56 | 0.00 |
2023-03-31 | 9.14 | $-1.51 | 0.00 |
2022-12-31 | 11.41 | $-1.44 | 0.00 |
2022-09-30 | 17.02 | $-1.41 | 0.00 |
2022-06-30 | 21.48 | $-1.32 | 0.00 |
2022-03-31 | 36.99 | $-0.95 | 0.00 |
2021-12-31 | 45.48 | $-0.59 | 0.00 |
2021-09-30 | 63.37 | $-0.35 | 0.00 |
2021-06-30 | 91.52 | $-0.18 | 0.00 |
2021-03-31 | 68.09 | $-0.29 | 0.00 |
2020-12-31 | 72.45 | $-0.42 | 0.00 |
2020-09-30 | 37.94 | $-0.46 | 0.00 |
2020-06-30 | 35.43 | $-0.44 | 0.00 |
2020-03-31 | 21.83 | $-0.48 | 0.00 |
2019-12-31 | 21.57 | $-0.52 | 0.00 |
2019-09-30 | 22.61 | $-0.50 | 0.00 |
2019-06-30 | 35.99 | $-1.00 | 0.00 |
2019-03-31 | 31.52 | $-1.21 | 0.00 |
2018-12-31 | 25.14 | $-1.33 | 0.00 |
2018-09-30 | 28.85 | $-2.37 | 0.00 |
2018-06-30 | 12.24 | $-2.46 | 0.00 |
2018-03-31 | 7.97 | $-2.25 | 0.00 |
2017-12-31 | 7.34 | $-2.21 | 0.00 |
2017-09-30 | 3.70 | $-1.81 | 0.00 |
2017-06-30 | 1.11 | $-1.44 | 0.00 |
2017-03-31 | 1.40 | $-2.01 | 0.00 |
2016-12-31 | 2.70 | $-2.56 | 0.00 |
2016-09-30 | 3.55 | $-2.23 | 0.00 |
2016-06-30 | 4.31 | $-2.26 | 0.00 |
2016-03-31 | 4.96 | $-1.77 | 0.00 |
2015-12-31 | 6.40 | $-1.15 | 0.00 |
2015-09-30 | 4.17 | $-0.75 | 0.00 |
2015-06-30 | 6.50 | $-0.34 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.545B | $0.280B |
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $120.995B | 15.70 |
Cencora (COR) | United States | $48.801B | 19.48 |
ICON (ICLR) | Ireland | $27.182B | 26.81 |
DiDi Global (DIDIY) | China | $18.509B | 0.00 |
Avantor (AVTR) | United States | $17.350B | 23.91 |
CochLear (CHEOY) | $14.477B | 0.00 | |
Viatris (VTRS) | United States | $14.192B | 4.05 |
Charles River Laboratories (CRL) | United States | $13.819B | 25.29 |
Revvity (RVTY) | United States | $13.021B | 22.67 |
Medpace Holdings (MEDP) | United States | $12.404B | 45.41 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $12.071B | 0.00 |
Natera (NTRA) | United States | $10.924B | 0.00 |
HealthEquity (HQY) | United States | $6.840B | 51.10 |
Amplifon S.p.A (AMFPF) | Italy | $6.762B | 34.33 |
Bausch + Lomb (BLCO) | Canada | $6.041B | 23.26 |
Doximity (DOCS) | United States | $5.035B | 37.49 |
Organon (OGN) | United States | $4.717B | 4.57 |
Surgery Partners (SGRY) | United States | $3.791B | 35.22 |
Progyny (PGNY) | United States | $3.666B | 61.27 |
Sotera Health (SHC) | United States | $3.357B | 16.49 |
Life Times (LTH) | United States | $3.031B | 33.50 |
GoodRx Holdings (GDRX) | United States | $2.769B | 140.20 |
Premier (PINC) | United States | $2.612B | 9.56 |
Teladoc Health (TDOC) | United States | $2.551B | 0.00 |
Agilon Health (AGL) | United States | $2.347B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.329B | 7.53 |
BrightSpring Health Services (BTSG) | United States | $1.739B | 0.00 |
NovoCure (NVCR) | Jersey | $1.568B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.381B | 0.00 | |
Agiliti (AGTI) | United States | $1.376B | 22.49 |
Alignment Healthcare (ALHC) | United States | $0.905B | 0.00 |
Pediatrix Medical (MD) | United States | $0.840B | 8.69 |
Embecta (EMBC) | United States | $0.743B | 4.90 |
InnovAge Holding (INNV) | United States | $0.590B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.588B | 0.00 |
Enhabit (EHAB) | United States | $0.580B | 52.54 |
Beauty Health (SKIN) | United States | $0.559B | 0.00 |
MultiPlan (MPLN) | United States | $0.544B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.466B | 12.21 |
DocGo (DCGO) | United States | $0.423B | 67.67 |
LifeMD (LFMD) | United States | $0.411B | 0.00 |
ModivCare (MODV) | United States | $0.354B | 4.69 |
Sera Prognostics (SERA) | United States | $0.296B | 0.00 |
Sharecare (SHCR) | United States | $0.296B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.287B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.246B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.237B | 0.00 |
Biodesix (BDSX) | United States | $0.140B | 0.00 |
Oncology Institute (TOI) | United States | $0.136B | 0.00 |
So-Young (SY) | China | $0.108B | 36.00 |
Pono Capital Two (PTWO) | United States | $0.070B | 0.00 |
Nutex Health (NUTX) | United States | $0.068B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
NeueHealth (NEUE) | United States | $0.052B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.039B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.038B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
OncoCyte (OCX) | United States | $0.025B | 0.00 |
DermTech (DMTK) | United States | $0.025B | 0.00 |
BIMI Medical (BIMI) | United States | $0.021B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.012B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.010B | 0.00 |
OpGen (OPGN) | United States | $0.007B | 0.00 |
XWELL (XWEL) | United States | $0.007B | 0.00 |
Assure Holdings (IONM) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.001B | 0.00 |